Test Prep for Nurses

Tpfn og share

High-Yield Nursing Drug Guide – Free NCLEX Pharmacology Cards

Free Reference

High-Yield Nursing Pharmacology Drug Guide

The 25 most-tested NCLEX medications on quick-reference cards – drug class, use, key nursing considerations, and the single safety pearl most likely to show up on your exam (antidotes, labs to monitor, toxicity signs).

heparin

anticoagulant (unfractionated)
Use: prevention and treatment of venous thromboembolism and pulmonary embolism
  • Monitor aPTT every 6 hours; therapeutic range is 60 to 100 seconds (1.5 to 2.5 times control)
  • Assess for bleeding: hematuria, black tarry stools, unusual bruising, and gum bleeding
  • Never administer intramuscularly due to risk of hematoma; use subcutaneous or IV routes only
  • Have protamine sulfate available as the reversal agent
Key point: Antidote is protamine sulfate; monitor aPTT to guide dosing

warfarin (Coumadin)

anticoagulant (vitamin K antagonist)
Use: prevention of thromboembolic events in atrial fibrillation and mechanical heart valves
  • Monitor INR; therapeutic range is typically 2.0 to 3.0 (2.5 to 3.5 for mechanical valves)
  • Teach patient to avoid foods high in vitamin K such as leafy green vegetables and maintain consistent intake
  • Many drug interactions; NSAIDs, aspirin, and antibiotics can increase bleeding risk
  • Instruct patient to use a soft toothbrush, electric razor, and report unusual bleeding
Key point: Antidote is vitamin K (phytonadione); monitor INR regularly

insulin (regular and NPH)

antidiabetic hormone
Use: management of type 1 and type 2 diabetes mellitus and diabetic ketoacidosis
  • Monitor blood glucose before administration; hold and notify provider for hypoglycemia
  • Rotate injection sites within the same region to prevent lipodystrophy
  • Regular insulin is the only insulin that can be given intravenously
  • Teach patient signs of hypoglycemia: shakiness, diaphoresis, confusion, and tachycardia
Key point: Only regular insulin is given IV; hypoglycemia is the primary safety concern

digoxin (Lanoxin)

cardiac glycoside
Use: management of heart failure and rate control in atrial fibrillation
  • Check apical pulse for one full minute before administration; hold if less than 60 beats per minute
  • Monitor serum digoxin level; therapeutic range is 0.5 to 2.0 ng/mL
  • Hypokalemia increases risk of digoxin toxicity; monitor potassium levels
  • Teach patient to report nausea, vomiting, visual changes (yellow-green halos), and bradycardia
Key point: Hypokalemia potentiates digoxin toxicity; antidote is digoxin immune Fab (Digibind)

furosemide (Lasix)

loop diuretic
Use: treatment of edema associated with heart failure, renal disease, and hypertension
  • Monitor serum potassium; furosemide causes potassium wasting and can lead to hypokalemia
  • Assess blood pressure before and after administration; risk of orthostatic hypotension
  • Monitor intake and output and daily weight to assess fluid balance
  • Ototoxicity (hearing loss) can occur, especially with rapid IV infusion or high doses
Key point: Monitor potassium levels; ototoxicity risk with rapid IV administration

metoprolol (Lopressor, Toprol-XL)

selective beta-1 adrenergic blocker
Use: treatment of hypertension, angina, and heart failure
  • Assess heart rate and blood pressure before administration; hold if heart rate is less than 60 or systolic BP is less than 90
  • Do not abruptly discontinue; taper gradually to avoid rebound hypertension and angina
  • Use caution in patients with asthma or COPD; can cause bronchospasm even though selective
  • Monitor blood glucose in diabetic patients; beta blockers can mask hypoglycemia symptoms
Key point: Never stop abruptly; taper to prevent rebound hypertension and potential myocardial infarction

lisinopril (Prinivil, Zestril)

ACE inhibitor
Use: treatment of hypertension, heart failure, and diabetic nephropathy
  • Monitor for dry, persistent, non-productive cough which is the most common side effect
  • Monitor serum potassium and renal function; can cause hyperkalemia and renal impairment
  • Contraindicated in pregnancy (category D/X); can cause fetal renal damage and death
  • Monitor for angioedema: swelling of face, lips, tongue, or throat requiring immediate discontinuation
Key point: Angioedema is a life-threatening adverse effect; contraindicated in pregnancy

morphine sulfate

opioid analgesic (narcotic)
Use: management of moderate to severe acute and chronic pain
  • Monitor respiratory rate; hold if less than 12 breaths per minute and notify provider
  • Assess pain level, sedation level, and level of consciousness before and after administration
  • Have naloxone (Narcan) available at bedside for respiratory depression reversal
  • Monitor for constipation and implement bowel regimen; opioids slow GI motility
Key point: Antidote is naloxone; priority assessment is respiratory rate before each dose

acetaminophen (Tylenol)

non-opioid analgesic and antipyretic
Use: management of mild to moderate pain and fever reduction
  • Maximum adult dose is 4 grams per day; reduce to 2 grams per day in patients with liver disease or heavy alcohol use
  • Educate patient to check all OTC medications for acetaminophen content to avoid unintentional overdose
  • Monitor liver function tests; hepatotoxicity is the major toxicity concern
  • Assess for chronic alcohol use as it significantly increases liver toxicity risk
Key point: Antidote for overdose is acetylcysteine (Mucomyst); hepatotoxicity is the major concern

prednisone (Deltasone)

corticosteroid (glucocorticoid)
Use: treatment of inflammatory and autoimmune conditions and allergic reactions
  • Monitor blood glucose; corticosteroids cause hyperglycemia and can unmask or worsen diabetes
  • Never stop abruptly after long-term use; taper dose to prevent adrenal insufficiency
  • Monitor for signs of infection; corticosteroids suppress the immune system and mask fever
  • Teach patient to take with food to reduce GI upset and report weight gain, moon face, and mood changes
Key point: Never discontinue abruptly after prolonged use; adrenal suppression requires tapering

albuterol (ProAir, Ventolin)

short-acting beta-2 adrenergic agonist (SABA) bronchodilator
Use: relief of acute bronchospasm in asthma and COPD
  • Assess lung sounds, respiratory rate, and oxygen saturation before and after administration
  • Monitor heart rate; albuterol can cause tachycardia and palpitations
  • Teach patient correct inhaler technique including spacer use and breath-holding for 10 seconds
  • If using multiple inhalers, administer bronchodilator (albuterol) before corticosteroid inhaler
Key point: Used first (rescue) in asthma attack; monitor for tachycardia as a common side effect

phenytoin (Dilantin)

hydantoin anticonvulsant
Use: prevention and treatment of generalized tonic-clonic and complex partial seizures
  • Monitor serum phenytoin levels; therapeutic range is 10 to 20 mcg/mL
  • Administer IV no faster than 50 mg per minute; rapid IV administration causes cardiovascular collapse
  • Only mix with normal saline; glucose solution causes precipitation
  • Teach patient about gingival hyperplasia and emphasize oral hygiene; also can cause hirsutism and ataxia
Key point: IV rate must not exceed 50 mg/minute; monitor for cardiac dysrhythmias and hypotension during IV infusion

lithium (Lithobid)

mood stabilizer
Use: treatment and prevention of manic episodes in bipolar disorder
  • Monitor serum lithium levels; therapeutic range is 0.6 to 1.2 mEq/L; toxicity occurs above 1.5 mEq/L
  • Maintain adequate sodium and fluid intake; sodium depletion causes lithium retention and toxicity
  • Monitor renal and thyroid function; lithium can cause nephrogenic diabetes insipidus and hypothyroidism
  • Teach patient early toxicity signs: fine hand tremor, nausea, diarrhea, and mild thirst
Key point: Narrow therapeutic index; dehydration and low sodium diet increase toxicity risk

levothyroxine (Synthroid, Levoxyl)

thyroid hormone replacement
Use: treatment of hypothyroidism and thyroid hormone replacement after thyroidectomy
  • Administer on an empty stomach 30 to 60 minutes before breakfast for optimal absorption
  • Do not take within 4 hours of calcium, iron, or antacids as they reduce absorption
  • Monitor TSH levels to assess therapeutic response; normal TSH indicates adequate dosing
  • Teach patient signs of excessive dosing: palpitations, chest pain, nervousness, heat intolerance, and weight loss
Key point: Take on empty stomach consistently; monitor TSH to assess adequacy of therapy

potassium chloride (K-Dur, Klor-Con)

electrolyte replacement
Use: treatment and prevention of hypokalemia
  • IV potassium must always be diluted; never administer as undiluted IV push as it can cause cardiac arrest
  • IV infusion rate should not exceed 10 to 20 mEq per hour; monitor cardiac rhythm during IV administration
  • Oral potassium should be taken with food or a full glass of water to reduce GI irritation
  • Monitor serum potassium, ECG, urine output, and renal function throughout therapy
Key point: Never give IV potassium undiluted or as IV push; fatal cardiac arrest can result

metformin (Glucophage)

biguanide antidiabetic
Use: first-line treatment of type 2 diabetes mellitus
  • Hold 24 to 48 hours before and after IV contrast dye procedures due to risk of lactic acidosis
  • Monitor renal function; contraindicated when GFR is less than 30 mL/min/1.73m2
  • Most common side effects are GI: nausea, diarrhea, and abdominal discomfort; take with meals to minimize
  • Does not cause hypoglycemia when used as monotherapy; low risk compared to sulfonylureas
Key point: Hold before IV contrast; risk of lactic acidosis in renal impairment is the key safety concern

atorvastatin (Lipitor)

HMG-CoA reductase inhibitor (statin)
Use: treatment of hyperlipidemia and prevention of cardiovascular disease
  • Monitor liver function tests at baseline and periodically during therapy
  • Instruct patient to report unexplained muscle pain, tenderness, or weakness immediately (myopathy or rhabdomyolysis)
  • Avoid grapefruit juice as it inhibits metabolism and increases statin concentration and toxicity
  • Administer at bedtime as cholesterol synthesis is highest overnight, though atorvastatin can be given any time
Key point: Monitor for myopathy and rhabdomyolysis; check CK levels if muscle pain occurs

nitroglycerin (Nitrostat, Nitro-Bid)

nitrate vasodilator
Use: treatment and prevention of angina pectoris and acute coronary syndromes
  • Instruct patient to sit or lie down before taking sublingual nitroglycerin to prevent falls from hypotension
  • May repeat sublingual dose every 5 minutes for up to 3 doses; call 911 if chest pain unrelieved after first dose
  • Rotate transdermal patch sites and remove old patch before applying new one; remove at night to prevent tolerance
  • Store sublingual tablets in original dark glass bottle; replace every 6 months as potency diminishes
Key point: Headache and hypotension are common; call emergency services if chest pain persists after 3 sublingual doses in 15 minutes

naloxone (Narcan)

opioid antagonist
Use: reversal of opioid-induced respiratory depression and opioid overdose
  • Duration of naloxone is shorter than most opioids; patient may lapse back into respiratory depression and require redosing
  • Monitor respiratory rate, oxygen saturation, and level of consciousness continuously after administration
  • May precipitate acute opioid withdrawal in opioid-dependent patients: agitation, nausea, vomiting, and tachycardia
  • Intranasal and IM formulations are available for community use in opioid overdose emergencies
Key point: Shorter half-life than opioids; monitor closely for return of respiratory depression after initial reversal

magnesium sulfate

electrolyte and anticonvulsant
Use: prevention and treatment of seizures in preeclampsia and eclampsia; treatment of hypomagnesemia
  • Monitor respirations, deep tendon reflexes (DTRs), and urine output; hold if respirations are less than 12 or DTRs are absent
  • Have calcium gluconate available at bedside as the antidote for magnesium toxicity
  • Monitor serum magnesium levels; therapeutic anticonvulsant range is 4 to 7 mEq/L; toxicity above 7 mEq/L
  • Assess urine output; minimum of 25 to 30 mL per hour required for safe magnesium excretion
Key point: Antidote is calcium gluconate; loss of deep tendon reflexes is the earliest sign of toxicity

vancomycin (Vancocin)

glycopeptide antibiotic
Use: treatment of serious gram-positive infections including MRSA
  • Monitor serum vancomycin trough levels before the fourth dose; therapeutic trough is 10 to 20 mcg/mL
  • Monitor renal function (BUN and creatinine) and urine output; vancomycin is nephrotoxic
  • Infuse IV slowly over at least 60 minutes to prevent Red Man Syndrome: flushing, erythema, and hypotension
  • Monitor for ototoxicity: tinnitus and hearing loss, especially with concurrent aminoglycoside use
Key point: Red Man Syndrome from rapid infusion is prevented by slowing infusion rate; monitor renal function and trough levels

amiodarone (Cordarone, Pacerone)

class III antiarrhythmic
Use: treatment of life-threatening ventricular dysrhythmias and atrial fibrillation
  • Monitor thyroid function tests; amiodarone contains iodine and can cause both hypothyroidism and hyperthyroidism
  • Assess for pulmonary toxicity: new or worsening cough, dyspnea, and chest pain; obtain baseline and periodic chest X-ray
  • Monitor for corneal microdeposits and advise patient to report visual changes; regular ophthalmology exams recommended
  • Monitor liver function tests; hepatotoxicity can occur with long-term use
Key point: Multiple organ toxicities (pulmonary, thyroid, hepatic, corneal); requires baseline and ongoing monitoring of multiple systems

sertraline (Zoloft)

selective serotonin reuptake inhibitor (SSRI)
Use: treatment of major depressive disorder, anxiety disorders, PTSD, and OCD
  • Black box warning: increased risk of suicidal ideation in children, adolescents, and young adults up to age 24; monitor closely especially in first weeks
  • Full therapeutic effect takes 4 to 6 weeks; educate patient not to stop medication if they do not feel immediate improvement
  • Do not discontinue abruptly; taper to prevent serotonin discontinuation syndrome: dizziness, flu-like symptoms, and irritability
  • Monitor for serotonin syndrome with concurrent use of other serotonergic drugs: hyperthermia, agitation, and muscle rigidity
Key point: Black box warning for suicidality in young patients; monitor closely in first few weeks of therapy

aspirin (Bayer, Ecotrin)

salicylate, antiplatelet, NSAID
Use: antiplatelet therapy for prevention of myocardial infarction and stroke; pain and fever relief
  • Assess for aspirin allergy and cross-reactivity with NSAIDs before administration
  • Monitor for GI bleeding: black tarry stools, hematemesis; take with food or milk to reduce GI irritation
  • Teach patient to recognize salicylate toxicity (salicylism): tinnitus, hearing loss, dizziness, and tachypnea
  • Do not give aspirin to children or teenagers with viral illness due to risk of Reye syndrome
Key point: Contraindicated in children with viral illness due to Reye syndrome; tinnitus is an early sign of toxicity

enoxaparin (Lovenox)

low molecular weight heparin (LMWH) anticoagulant
Use: prevention and treatment of deep vein thrombosis and pulmonary embolism
  • Administer subcutaneously in the abdomen; do not aspirate or rub the injection site after administration
  • aPTT monitoring is generally not required for routine dosing unlike unfractionated heparin; anti-Xa levels used if monitoring needed
  • Use with caution in patients with renal impairment; dose adjustment required when GFR is less than 30 mL/min
  • Assess for heparin-induced thrombocytopenia (HIT) and monitor platelet counts; cross-reactivity with heparin is possible
Key point: Do not rub injection site after administration; protamine sulfate only partially reverses LMWH anticoagulation

Drill pharmacology questions

Pharmacology is one of the eight NCLEX categories. Practice it free.

Pharmacology practice test